Kim Sablich, EVP, GM of U.S, Commercial Ma at Jazz Pharmaceuticals plc (JAZZ), sold 6,026 shares at $140.19 ($842K) on 2023-03-08, disclosed to the SEC on 2023-03-10.
Open-market sale of $842k JAZZ by EVP, GM of U.S, Commercial Ma. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.42 | 1,752 | $244K | 29.0% |
| 2 | $139.42 | 1,752 | $244K | 29.0% |
| 3 | $140.19 | 1,261 | $177K | 21.0% |
| 4 | $140.19 | 1,261 | $177K | 21.0% |
| Total | $139.74 avg | 6,026 | $842K | 100% |
| Filing → |
| MYOV | SELL | 2020-03-19 | $6K | — | Filing → |
| MYOV | SELL | 2020-01-16 | $136K | — | Filing → |
| MYOV | SELL | 2019-12-19 | $42K | — | Filing → |